CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

119 hedge funds and large institutions have $143M invested in CytomX Therapeutics in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+9
Holders Change %
+8.18%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
33
Reduced
42
Closed
14
Calls
$63K
Puts
$34K
Net Calls
+$29K
Net Calls Change
+$78K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$5.34M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.45M
3
Millennium Management
Millennium Management
New York
$6M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
$2.36M
5
Renaissance Technologies
Renaissance Technologies
New York
$2.39M

Top Sellers

1
Federated Hermes
Federated Hermes
Pennsylvania
$1K
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$11.7M
3
State Street
State Street
Massachusetts
$3.2M
4
O
OrbiMed
New York
$5.67M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Ohio Public Employees Retirement System (OPERS)
126
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$141K -32,609 Closed
SSA
127
Schonfeld Strategic Advisors
New York
– -$85K -19,800 Closed
MC
128
Manteio Capital
New Jersey
– -$65K -15,067 Closed
RJFSA
129
Raymond James Financial Services Advisors
Florida
– -$44K -10,227 Closed
2 3 4 5
6